FRTB may bite harder for Europe’s CVA modellers

Farther reach of advanced approach and lighter load on total requirements mean limited takeaways from Canada and Japan’s implementation

Five years on from its finalisation, Basel’s new framework for capitalising credit valuation adjustment (CVA) risk – the potential for a derivative contract to drop in value following changes in market or counterparty risk – is becoming populated by more and more dealers as countries gradually adopt the Fundamental Review of the Trading Book.

While the market risk pillar of FRTB has received the bulk of the industry’s attention – due to how radically it upset dealers’ modelling-costs-versus-capital-savings calculus – it is CVA capitalisation that may have seen the most sweeping overhaul, due to the complete removal of a modelling option. As rulemakers put it in 2017, CVA risk is fiendishly complex, more so than most trading book risks, and as such, “cannot be modelled by banks in a robust and prudent manner”.

Dealers in Canada, Japan and now Switzerland have provided the petri dishes for banks elsewhere – primarily the European Union and the UK – to gauge how their own capital charges may be reshaped.

Among the main takeaways so far: counterparty credit spreads weigh more heavily than market risk; the impact of hedges can vary widely; and going for the bare-bones basic approach over the authorisation-only standardised approach does not necessarily make for exploding risk-weighted assets (RWAs).

Generally, banks in Japan and Canada did not see CVA gobble up a larger share of their capital on switching to FRTB, with the component’s proportion of total RWAs mostly flat or down. Royal Bank of Canada and Mitsubishi UFJ Financial Group provided the exceptions, but still saw relatively contained rises of 28 basis points and 50bp, respectively.

 

This may bode well for dealers next in line to adopt FRTB, as it would imply little to no RWA inflation relative to the rest of the capital requirement stack. Nevertheless, the devil is in the detail.

Whereas only two of the banks that already went through the FRTB switch used to employ the advanced approach for modelling their own CVA charges – Scotiabank and UBS, rising to three when including Nomura, which only became subject to the new framework last week – the count rises significantly in countries that will next adopt the new regime. Among 37 EU and UK dealers tracked by Risk Quantum, 14 are advanced approach users.

Additionally, the fact that CVA charges weigh far less on EU and UK banks’ RWA load – with the most recent available data showing only three banks surpassed, barely, the 1% mark – could be read as being anomalously low, in which case the FRTB switch could herald a major increase, bringing some single-bank proportions of CVA capital in line with those experience by Canadian or Japanese dealers.

 

For major dealers, UBS provides perhaps the best litmus test. CVA RWAs – which it used to model – were 1.8% of the total as of December 31, a level the bank had last seen in the fourth quarter of 2016.

The next day, as FRTB came into effect, CVA RWAs rose by $2.6 billion, and their capture of total requirements to 2.3%. Assuming the underlying exposures were unchanged, the CVA risk density rose from 10.9% as of December 31 – with density of 4.9% on modelled charges offsetting the 23.9% on standardised one – to an implied figure of 14.1% on January 1.

The more burdensome CVA requirement is hardly impossible to manage for UBS. The bank’s book may also contain idiosyncrasies that made it more susceptible to RWA inflation, courtesy of the baggage it carries over from the legacy Credit Suisse balance sheet.

Still, its example fuels the idea that, come their respective implementation days – at the turns of 2026 and 2027, respectively – certain EU and UK banks may suddenly have to deal with a larger CVA load than they had been used to.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here